GENNEX logo

Gennex Laboratories Ltd

GENNEX·BSE·
12.15 +0.35 (+2.97%)
Market Cap292.51 Cr
PE Ratio15.19
Volume3,00,504
Day High - Low12.38 - 11.75
52W High-Low16.20 - 7.05
DocStoX Score
6.1/10
Fair
Fair Value
Sign in to see
ROE
9.25%
Average
P/E
15.19x
Fair
Debt / Equity
0.36
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Fair

Price performance

Day11.75
12.38
52W7.05
16.20
DocStoX take

Supported by growth (10.0), but held back by quality (3.9).

DocStoX score

Low confidence
6.1
/10
Fair
Quality
Modest
ROE 9.3%
Valuation
Fair
P/E 15.2×
Growth
Strong
Revenue +23.6% 5Y CAGR
Risk
Moderate
D/E 0.36
Momentum
Firm
56% of 52-week range

At a glance

Market Cap
₹293 Cr
52W High / Low
₹16 / ₹7
Dividend Yield
0.00%
Promoter Holding
23.63%
EPS (TTM)
₹0.80
Book Value
₹9.16

Key highlights

  • Profit compounding 40% a year
  • Profitable in all of the last 5 years
  • Revenue compounding 24% a year
  • Small ₹293 cr company — thinner liquidity
3 Positives1 Watchout

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Gennex Laboratories Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Gennex Laboratories Ltd (GENNEX) Share Price at ₹12.15 (+2.97%) | DocStoX